Amneal Pharmaceuticals, Inc.AMRXNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$220.11M
↑ 93% above average
Average (9y)
$113.75M
Historical baseline
Range
High:$317.16M
Low:$-95.73M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $220.11M | -20.4% |
| 2023 | $276.39M | +1184.1% |
| 2022 | $-25.50M | -113.1% |
| 2021 | $194.09M | -38.8% |
| 2020 | $317.16M | +431.3% |
| 2019 | $-95.73M | -162.5% |
| 2018 | $153.14M | +27.7% |
| 2017 | $119.92M | +1356.2% |
| 2016 | $-9.55M | +23.6% |
| 2015 | $-12.50M | - |